ALT Annual ROE
-46.63%
-2.56%-5.81%
31 December 2023
Summary:
As of January 23, 2025, ALT annual return on equity is -46.63%, with the most recent change of -2.56% (-5.81%) on December 31, 2023. During the last 3 years, it has fallen by -10.49% (-29.03%). ALT annual ROE is now -9616.33% below its all-time high of 0.49%, reached on December 31, 2005.ALT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALT Quarterly ROE
-64.43%
-3.94%-6.51%
30 September 2024
Summary:
As of January 23, 2025, ALT quarterly return on equity is -64.43%, with the most recent change of -3.94% (-6.51%) on September 30, 2024. Over the past year, it has dropped by -13.32% (-26.06%). ALT quarterly ROE is now -106.47% below its all-time high of 995.50%, reached on December 31, 2010.ALT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALT ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -5.8% | -26.1% |
3 y3 years | -29.0% | -72.5% |
5 y5 years | +42.3% | +20.4% |
ALT ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -5.8% | at low | -48.9% | at low |
5 y | 5-year | -29.0% | at low | -87.9% | +1.6% |
alltime | all time | -9616.3% | +89.7% | -106.5% | +98.9% |
Altimmune ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -64.43%(+6.5%) |
June 2024 | - | -60.49%(+11.2%) |
Mar 2024 | - | -54.38%(+6.4%) |
Dec 2023 | -46.63%(+5.8%) | -51.11%(+14.1%) |
Sept 2023 | - | -44.78%(+1.4%) |
June 2023 | - | -44.18%(-3.0%) |
Mar 2023 | - | -45.53%(+4.1%) |
Dec 2022 | -44.07%(-3.5%) | -43.72%(-0.1%) |
Sept 2022 | - | -43.78%(-7.0%) |
June 2022 | - | -47.10%(+0.2%) |
Mar 2022 | - | -47.02%(+8.7%) |
Dec 2021 | -45.69%(+26.4%) | -43.27%(+15.9%) |
Sept 2021 | - | -37.34%(+8.9%) |
June 2021 | - | -34.29%(-9.3%) |
Mar 2021 | - | -37.82%(-8.6%) |
Dec 2020 | -36.14%(-17.4%) | -41.39%(-19.0%) |
Sept 2020 | - | -51.10%(-21.9%) |
June 2020 | - | -65.47%(+48.1%) |
Mar 2020 | - | -44.20%(+11.5%) |
Dec 2019 | -43.74%(-45.8%) | -39.65%(-51.0%) |
Sept 2019 | - | -80.92%(+20.0%) |
June 2019 | - | -67.42%(-18.5%) |
Mar 2019 | - | -82.77%(-7.2%) |
Dec 2018 | -80.77%(-29.6%) | -89.23%(+73.4%) |
Sept 2018 | - | -51.47%(-46.7%) |
June 2018 | - | -96.49%(+5.6%) |
Mar 2018 | - | -91.40%(-8.7%) |
Dec 2017 | -114.79%(+152.9%) | -100.06%(+57.4%) |
Sept 2017 | - | -63.59%(+134.6%) |
June 2017 | - | -27.10%(-12.6%) |
Mar 2017 | - | -31.02%(+30.5%) |
Dec 2016 | -45.39%(+130.4%) | -23.77%(+12.8%) |
Sept 2016 | - | -21.08%(-27.9%) |
June 2016 | - | -29.22%(-15.8%) |
Mar 2016 | - | -34.71%(+83.6%) |
Dec 2015 | -19.70% | -18.91%(-27.7%) |
Sept 2015 | - | -26.14%(-45.0%) |
June 2015 | - | -47.52%(+15.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2015 | - | -41.23%(-47.9%) |
Dec 2014 | -77.75%(-36.9%) | -79.13%(-24.6%) |
Sept 2014 | - | -104.94%(-3.1%) |
June 2014 | - | -108.30%(-8.4%) |
Mar 2014 | - | -118.23%(+8.0%) |
Dec 2013 | -123.29%(+244.9%) | -109.46%(+50.2%) |
Sept 2013 | - | -72.89%(+83.8%) |
June 2013 | - | -39.65%(+12.0%) |
Mar 2013 | - | -35.39%(-3.0%) |
Dec 2012 | -35.75%(+32.1%) | -36.50%(+76.8%) |
Sept 2012 | - | -20.65%(+9.0%) |
June 2012 | - | -18.95%(-40.5%) |
Mar 2012 | - | -31.87%(+13.3%) |
Dec 2011 | -27.07%(-94.0%) | -28.13%(-89.1%) |
Sept 2011 | - | -257.53%(-66.8%) |
June 2011 | - | -776.51%(-86.3%) |
Mar 2011 | - | -5679.71%(-670.5%) |
Dec 2010 | -453.67%(+55.4%) | 995.50%(+135.8%) |
Sept 2010 | - | 422.14%(-112.8%) |
June 2010 | - | -3289.10%(+502.5%) |
Mar 2010 | - | -545.88%(+87.7%) |
Dec 2009 | -291.92%(+138.6%) | -290.77%(+16.1%) |
Sept 2009 | - | -250.38%(+62.0%) |
June 2009 | - | -154.60%(-19.4%) |
Mar 2009 | - | -191.75%(+28.0%) |
Dec 2008 | -122.33%(+74.3%) | -149.80%(+20.9%) |
Sept 2008 | - | -123.86%(+48.0%) |
June 2008 | - | -83.70%(+177.2%) |
Mar 2008 | - | -30.19%(+39.1%) |
Dec 2007 | -70.18%(+25.8%) | -21.71%(+9.0%) |
Sept 2007 | - | -19.91%(-38.3%) |
June 2007 | - | -32.28%(+28.3%) |
Mar 2007 | - | -25.15%(+37.4%) |
Dec 2006 | -55.79%(<-9900.0%) | -18.31%(+239.1%) |
Sept 2006 | - | -5.40%(-415.8%) |
June 2006 | - | 1.71%(+48.7%) |
Mar 2006 | - | 1.15%(+53.3%) |
Dec 2005 | 0.49% | 0.75%(+44.2%) |
Sept 2005 | - | 0.52% |
FAQ
- What is Altimmune annual return on equity?
- What is the all time high annual ROE for Altimmune?
- What is Altimmune annual ROE year-on-year change?
- What is Altimmune quarterly return on equity?
- What is the all time high quarterly ROE for Altimmune?
- What is Altimmune quarterly ROE year-on-year change?
What is Altimmune annual return on equity?
The current annual ROE of ALT is -46.63%
What is the all time high annual ROE for Altimmune?
Altimmune all-time high annual return on equity is 0.49%
What is Altimmune annual ROE year-on-year change?
Over the past year, ALT annual return on equity has changed by -2.56% (-5.81%)
What is Altimmune quarterly return on equity?
The current quarterly ROE of ALT is -64.43%
What is the all time high quarterly ROE for Altimmune?
Altimmune all-time high quarterly return on equity is 995.50%
What is Altimmune quarterly ROE year-on-year change?
Over the past year, ALT quarterly return on equity has changed by -13.32% (-26.06%)